Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
C. Riccay Elizondo, Jennifer D. Bright, Jennifer A. Byrne & Robert K. Bright. (2020) Analysis of the CD8+ IL-10+ T cell response elicited by vaccination with the oncogenic tumor-self protein D52. Human Vaccines & Immunotherapeutics 16:6, pages 1413-1423.
Read now
Read now
Ying Zhang, Jin-An Ma, Hai-Xia Zhang, Yu-Na Jiang & Wen-Hao Luo. (2020) Cancer vaccines: Targeting KRAS-driven cancers. Expert Review of Vaccines 19:2, pages 163-173.
Read now
Read now
Robert K Bright, Jennifer D Bright & Jennifer A Byrne. (2014) Overexpressed oncogenic tumor-self antigens. Human Vaccines & Immunotherapeutics 10:11, pages 3297-3305.
Read now
Read now
Koichi Shimizu, Yoshihito Kotera, Atsushi Aruga, Nobuhiro Takeshita, Satoshi Katagiri, Shun-ichi Ariizumi, Yutaka Takahashi, Kenji Yoshitoshi, Ken Takasaki & Masakazu Yamamoto. (2014) Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma. Human Vaccines & Immunotherapeutics 10:4, pages 970-976.
Read now
Read now
Ryuji Okuyama, Atsushi Aruga, Takashi Hatori, Kazuyoshi Takeda & Masakazu Yamamoto. (2013) Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients. OncoImmunology 2:11.
Read now
Read now
Chizuru Ogi & Atsushi Aruga. (2013) Immunological monitoring of anticancer vaccines in clinical trials. OncoImmunology 2:8.
Read now
Read now
Atsushi Aruga. (2013) Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens. OncoImmunology 2:7.
Read now
Read now
Articles from other publishers (18)
Eman I.K. Ibrahim, Espen B. Ellingsen, Sara M. Mangsbo & Lena E. Friberg. (2024) Bridging responses to a human telomerase reverse transcriptase-based peptide cancer vaccine candidate in a mechanism-based model. International Immunopharmacology 126, pages 111225.
Crossref
Crossref
Khizra Mujahid, Isra Rana, Ivan Hardianto Suliman, Zhen Li, Jiang Wu, Huacheng He & Jutaek Nam. (2023) Biomaterial-Based Sustained-Release Drug Formulations for Localized Cancer Immunotherapy. ACS Applied Bio Materials.
Crossref
Crossref
Stuti Srivastava, Devendra Singh, Sunil Kumar Verma, Minakshi Pandey, Avinash Sharma, Himanshu Pandey & Anshu Mishra. (2023) Recent advancements in cancer vaccines: A systematic review. Vacunas.
Crossref
Crossref
Morgan E. Janes, Alexander P. Gottlieb, Kyung Soo Park, Zongmin Zhao & Samir Mitragotri. (2023) Cancer vaccines in the clinic. Bioengineering & Translational Medicine.
Crossref
Crossref
Dmitri Loukinov, Amanda Laust Anderson, Mikayel Mkrtichyan, Anahit Ghochikyan, Samuel Rivero-Hinojosa, Jo Tucker, Victor Lobanenkov, Michael G. Agadjanyan & Edward L. Nelson. (2023) A Therapeutic Vaccine Targeting Rat BORIS (CTCFL) for the Treatment of Rat Breast Cancer Tumors. International Journal of Molecular Sciences 24:6, pages 5976.
Crossref
Crossref
Mohammad Ejaz & Muhammad Ali Syed. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
21
.
Daniel Sur, Alecsandra Gorzo & Claudia Burz. 2022. Recent Understanding of Colorectal Cancer Treatment. Recent Understanding of Colorectal Cancer Treatment.
Saroj Verma, Neeraj Masand, Rameshwar S. Cheke & Vaishali M. Patil. (2022) Protein Informatics and Vaccine Development: Cancer Case Study. Current Topics in Medicinal Chemistry 22:26, pages 2207-2220.
Crossref
Crossref
Kamya Goyal, Bharti Mangla, Navdeep Singh, Honey Goel, Kunal Goyal, Shammy Jindal, Mohammad Javed Ansari & Waleed H. Almalki. 2022. Nanotherapeutics in Cancer Vaccination and Challenges. Nanotherapeutics in Cancer Vaccination and Challenges
325
348
.
Qian Wei, Zhao-Yuan Fang, Zi-Meng Zhang & Teng-Fei Zhang. (2021) Therapeutic tumor vaccines — a rising star to benefit cancer patients. WArtificial Intelligence in Cancer 2:3, pages 25-41.
Crossref
Crossref
Michael A. Morse, William R. GwinIIIIII & Duane A. Mitchell. (2021) Vaccine Therapies for Cancer: Then and Now. Targeted Oncology 16:2, pages 121-152.
Crossref
Crossref
David J. Zahavi & Louis M. Weiner. 2019. Cancer Immunotherapy. Cancer Immunotherapy
61
100
.
Mahsa Keshavarz-Fathi & Nima Rezaei. 2019. Vaccines for Cancer Immunotherapy. Vaccines for Cancer Immunotherapy
153
160
.
Ting‐Yu Shih, Serena O. Blacklow, Aileen W. Li, Benjamin R. Freedman, Sidi Bencherif, Sandeep T. Koshy, Max C. Darnell & David J. Mooney. (2018) Injectable, Tough Alginate Cryogels as Cancer Vaccines. Advanced Healthcare Materials 7:10, pages 1701469.
Crossref
Crossref
H.F. Florindo, J. Lopes, L.C. Silva, M.L. Corvo, M.B. Martins & R. Gaspar. 2017. Micro and Nanotechnology in Vaccine Development. Micro and Nanotechnology in Vaccine Development
393
410
.
Chizuru Ogi & Atsushi Aruga. (2015) Approaches to improve development methods for therapeutic cancer vaccines. Immunology Letters 164:2, pages 100-108.
Crossref
Crossref
Huining He, Junxiao Ye, Yinsong Wang, Quan Liu, Hee Sun Chung, Young Min Kwon, Meong Cheol Shin, Kyuri Lee & Victor C. Yang. (2014) Cell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application. Journal of Controlled Release 176, pages 123-132.
Crossref
Crossref
Atsushi Aruga, Nobuhiro Takeshita, Yoshihito Kotera, Ryuji Okuyama, Norimasa Matsushita, Takehiro Ohta, Kazuyoshi Takeda & Masakazu Yamamoto. (2014) Phase I clinical trial of multiple-peptide vaccination for patients with advanced biliary tract cancer. Journal of Translational Medicine 12:1, pages 61.
Crossref
Crossref